Cabozantinib and Pembrolizumab in Metastatic Pancreas
Condition: Pancreatic Cancer Interventions: Drug: Cabozantinib; Drug: Pembrolizumab Sponsors: Joseph Kim; Exelixis; Merck Sharp & Dohme Corp. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials